Wuhan Keqian Biology Secures New Veterinary Drug Registration Certificate

Stock News02-09

Wuhan Keqian Biology Co., Ltd. (688526.SH) has announced that following a review by the Ministry of Agriculture and Rural Affairs of the People's Republic of China, in accordance with the "Regulations on the Administration of Veterinary Drugs" and the "Measures for Veterinary Drug Registration," the company's application for a Porcine Circovirus Type 2 Recombinant Baculovirus Inactivated Vaccine (CH17 Strain, Suspension Culture) has been approved as a new veterinary drug. A "New Veterinary Drug Registration Certificate" has been issued. The successful approval of this product will further diversify the company's product portfolio, promote the diversification of its products and business, enhance its market competitiveness, and have a positive impact on its operational development.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1153582199?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-09 15:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153582199","market":"sh","top_or_hot":-1,"title":"Wuhan Keqian Biology Secures New Veterinary Drug Registration Certificate","media":"Stock News","content":"<p>Wuhan Keqian Biology Co., Ltd. (688526.SH) has announced that following a review by the Ministry of Agriculture and Rural Affairs of the People's Republic of China, in accordance with the \"Regulations on the Administration of Veterinary Drugs\" and the \"Measures for Veterinary Drug Registration,\" the company's application for a Porcine Circovirus Type 2 Recombinant Baculovirus Inactivated Vaccine (CH17 Strain, Suspension Culture) has been approved as a new veterinary drug. A \"New Veterinary Drug Registration Certificate\" has been issued. The successful approval of this product will further diversify the company's product portfolio, promote the diversification of its products and business, enhance its market competitiveness, and have a positive impact on its operational development.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wuhan Keqian Biology Secures New Veterinary Drug Registration Certificate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWuhan Keqian Biology Secures New Veterinary Drug Registration Certificate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-02-09 15:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Wuhan Keqian Biology Co., Ltd. (688526.SH) has announced that following a review by the Ministry of Agriculture and Rural Affairs of the People's Republic of China, in accordance with the \"Regulations on the Administration of Veterinary Drugs\" and the \"Measures for Veterinary Drug Registration,\" the company's application for a Porcine Circovirus Type 2 Recombinant Baculovirus Inactivated Vaccine (CH17 Strain, Suspension Culture) has been approved as a new veterinary drug. A \"New Veterinary Drug Registration Certificate\" has been issued. The successful approval of this product will further diversify the company's product portfolio, promote the diversification of its products and business, enhance its market competitiveness, and have a positive impact on its operational development.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"","article_id":"1153582199","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153582199","pubTimestamp":1770623247,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Wuhan Keqian Biology Co., Ltd. (688526.SH) has announced that following a review by the Ministry of Agriculture and Rural Affairs of the People's Republic of China, in accordance with the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688526":"科前生物","BK0239":"医药制造"},"translate_title":"武汉科前生物获新兽药注册证","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688526":1},"content_text":"Wuhan Keqian Biology Co., Ltd. (688526.SH) has announced that following a review by the Ministry of Agriculture and Rural Affairs of the People's Republic of China, in accordance with the \"Regulations on the Administration of Veterinary Drugs\" and the \"Measures for Veterinary Drug Registration,\" the company's application for a Porcine Circovirus Type 2 Recombinant Baculovirus Inactivated Vaccine (CH17 Strain, Suspension Culture) has been approved as a new veterinary drug. A \"New Veterinary Drug Registration Certificate\" has been issued. The successful approval of this product will further diversify the company's product portfolio, promote the diversification of its products and business, enhance its market competitiveness, and have a positive impact on its operational development.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1153582199","isCrawlerRequest":true}